Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/11/2008
 
First Published:
2/17/2006
1.
Phase III Randomized Study of Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Capecitabine for Breast and/or Other Cancer (Treatment Arms I-IV Closed to Accrual as of 10/25/2007)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
18 and over
NCI, Pharmaceutical / Industry
NCCTG-N05C5
ROCHE-NCCTG-N05C5, NCT00296036
Last Modified:
7/23/2008
 
First Published:
6/8/2007
2.
Phase III Randomized Study of Pyridoxine Hydrochloride for Prevention of Capecitabine-Induced Palmar-Plantar Erythrodysesthesia in Patients With Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
18 and over
Other
SINGAPORE-06-22-OTH
06-22-OTH, NCT00486213
Last Modified:
5/1/2008
 
First Published:
11/12/2007
3.
Phase III Randomized Study of Pyridoxine Hydrochloride in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Capecitabine for Colorectal or Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
18 and over
Other
CRCA-CCTC-CAPP-IT
EUDRACT-2004-000325-29, EU-20786, ISRCTN82842634, CCTC-CAPP-IT, NCT00559858
4.
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
18 and over
Other
INST 0553C
NCT00659269
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute